The aberrant expression of cadherin-6 correlates with a poor prognosis in patients with E-cadherin-absent Renal cell carcinomas (RCC) and could be a useful tool to estimate the malignancy potential [40];. The gene discussed is CDH1; the disease is hereditary clear cell renal cell carcinoma.